Antonio Salgado is a biologist and received his Ph.D. degree in materials science and engineering, tissue engineering and hybrid materials, from the University of Minho, Portugal in 2005. His Ph.D. work consisted of the development of novel bone tissue engineering strategies based on starch-based 3D scaffold and was carried out in the 3B’s Research Group in collaboration with the National University of Singapore and University of Toronto. In 2005, he started a postdoctoral research at the University of Toronto, Toronto, Ontario, Canada, which was then continued at the Life and Health Sciences Research Institute (ICVS) in collaboration with the 3B’s Research Group, both at University of Minho, dedicated to CNS regeneration. Currently he is Junior PI at the Life and Health Sciences Research Institute (ICVS), School of Health Sciences, University of Minho, Portugal. His research interests are focused on the development of innovative therapies for CNS repair. His main areas of research are development of a novel generation of 3D scaffolds for spinal cord injury regeneration, nanoparticles for targeted intracellular drug delivery within the CNS, and role of mesenchymal progenitors isolated from different sources and their secretome in neuroprotection and repair within the injured CNS. He is the author of 24 papers, 8 book chapters, and more than 80 communications in international. He was also a Guest Editor for Current Stem Cell Research & Therapy on a special issue dedicated to “Adult Stem Cells and Tissue Engineering in CNS Regenerative Medicine”. He currently supervises 10 postgraduation students. Parallel to his research activity, he has been acting as a referee for several international journals and has acted as an external evaluator of foreign funding agencies. In 2008, he received a distinction by Fundação Calouste de Gulbenkian under the scope of the Gulbenkian Programme to support research in life sciences.
Biography Updated on 20 November 2011